<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JRA</journal-id>
<journal-id journal-id-type="hwp">spjra</journal-id>
<journal-id journal-id-type="nlm-ta">J Renin Angiotensin Aldosterone Syst</journal-id>
<journal-title>Journal of the Renin-Angiotensin-Aldosterone System</journal-title>
<issn pub-type="ppub">1470-3203</issn>
<issn pub-type="epub">1752-8976</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1470320311417273</article-id>
<article-id pub-id-type="publisher-id">10.1177_1470320311417273</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Molecular characterization and regulation of the angiotensin-converting enzyme type 2/Angiotensin-(1-7)/MAS receptor axis during the ovulation process in cattle</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Tonellotto dos Santos</surname><given-names>Joabel</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311417273">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ferreira</surname><given-names>Rogério</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311417273">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Gasperin</surname><given-names>Bernardo Garziera</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311417273">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Siqueira</surname><given-names>Lucas Carvalho</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311417273">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>de Oliveira</surname><given-names>João Francisco</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311417273">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Santos</surname><given-names>Robson AS</given-names></name>
<xref ref-type="aff" rid="aff2-1470320311417273">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Reis</surname><given-names>Adelina M</given-names></name>
<xref ref-type="aff" rid="aff2-1470320311417273">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Gonçalves</surname><given-names>Paulo Bayard</given-names></name>
<xref ref-type="aff" rid="aff1-1470320311417273">1</xref>
</contrib>
</contrib-group>
<aff id="aff1-1470320311417273"><label>1</label>Laboratory of Biotechnology and Animal Reproduction - BioRep, Federal University of Santa Maria, Santa Maria, RS, Brazil</aff>
<aff id="aff2-1470320311417273"><label>2</label>Department of Physiology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil</aff>
<author-notes>
<corresp id="corresp1-1470320311417273">Paulo Bayard Gonçalves, Departamento de Clínica de Grandes Animais, Hospital Veterinário, Universidade Federal de Santa Maria, 97105-900, Santa Maria, RS, Brazil. Email: <email>bayard@ufsm.br</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>3</month>
<year>2012</year>
</pub-date>
<volume>13</volume>
<issue>1</issue>
<fpage>91</fpage>
<lpage>98</lpage>
<permissions>
<copyright-statement>© SAGE Publications 2011</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>The objective of this study was to characterize the profiles of Ang-(1-7), MAS receptor, ACE<sub>2</sub>, NEP and PEP during the ovulatory process in cattle. For this study, 40 synchronized cows with follicular diameter ≥ 12 mm were ovariectomized at different time-points (0, 3, 6, 12 and 24 h) after i.m. application of gonadotropin-releasing hormone (GnRH) to induce a luteinizing hormone surge. Follicular fluid was collected for measuring Ang-(1-7) by radioimmunoassay. Theca and granulosa cells were isolated from the preovulatory follicles to evaluate the gene expression of MAS receptor, ACE<sub>2</sub>, NEP and PEP by qRT-PCR assay. Cross-contamination between theca and granulosa cells was tested by RT-PCR to detect cytochrome P450 aromatase (CYP19A1) and 17α-hydroxylase (CYP17A1) mRNA. Ang-(1-7) levels were constant until 12 h and then increased (<italic>p</italic> &lt; 0.05) at 24 h after GnRH. Messenger RNA expression of MAS, ACE<sub>2</sub>, NEP and PEP was detected in theca and granulosa cells at all time-points after GnRH. In granulosa cells, ACE<sub>2</sub>, NEP and PEP were differentially expressed after GnRH treatment (<italic>p</italic> &lt; 0.05). In conclusion, the Ang-(1-7), MAS receptor, ACE<sub>2</sub>, NEP and PEP profiles in preovulatory follicles indicate that Ang-(1-7) plays a role in the regulation of the ovulatory process in cattle.</p>
</abstract>
<kwd-group>
<kwd>ACE<sub>2</sub></kwd>
<kwd>angiotensin-(1-7)</kwd>
<kwd>bovine</kwd>
<kwd>MAS receptor</kwd>
<kwd>ovulation</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1470320311417273" sec-type="intro">
<title>Introduction</title>
<p>Ovulation in mammals resembles an inflammatory process, ending with the rupture of the ovulatory stigma and the release of oocyte. Follicles from <italic>Bos taurus</italic> cows acquire ovulatory capacity after reaching 12 mm in diameter.<sup><xref ref-type="bibr" rid="bibr1-1470320311417273">1</xref></sup> The luteinizing hormone (LH) surge promotes intense transcription and translation activity in the theca and granulosa cells. Protein synthesis associated with mRNA expression increases 1 h after the LH surge and remains elevated until prior to ovulation.<sup><xref ref-type="bibr" rid="bibr2-1470320311417273">2</xref></sup> However, the mechanisms that trigger and control these events are still not completely understood. The renin–angiotensin system (RAS) has emerged as an important local system in the regulation of reproductive events.<sup><xref ref-type="bibr" rid="bibr3-1470320311417273">3</xref>-<xref ref-type="bibr" rid="bibr8-1470320311417273">8</xref></sup> Among the peptides of the RAS, angiotensin II (AngII) is one of the major bioactive compounds. AngII receptors are present in theca and granulosa cells in cattle,<sup><xref ref-type="bibr" rid="bibr9-1470320311417273">9</xref></sup> and the levels of AngII increase after the LH surge.<sup><xref ref-type="bibr" rid="bibr10-1470320311417273">10</xref></sup> Also, we have previously demonstrated that saralasin (a competitive inhibitor of AngII) inhibits ovulation<sup><xref ref-type="bibr" rid="bibr4-1470320311417273">4</xref></sup> and oocyte maturation<sup><xref ref-type="bibr" rid="bibr6-1470320311417273">6</xref></sup> in cattle. Taken together, these results strongly suggest that AngII has an important biological role in ovulation.</p>
<p>Angiotensin-(1-7) (Ang-(1-7)) has been shown to be another important active compound of the RAS. This peptide results either from the cleavage of angiotensin I (AngI) by neutral endopeptidase (NEP) and prolyl endopeptidase (PEP),<sup><xref ref-type="bibr" rid="bibr5-1470320311417273">5</xref></sup> or from AngII by angiotensin-converting enzyme II (ACE<sub>2</sub>)<sup><xref ref-type="bibr" rid="bibr11-1470320311417273">11</xref></sup> and PEP.<sup><xref ref-type="bibr" rid="bibr12-1470320311417273">12</xref></sup> Ang-(1-7) acts through the G protein-coupled receptor MAS<sup><xref ref-type="bibr" rid="bibr13-1470320311417273">13</xref></sup> and can be specifically inhibited with d-Ala7-Ang-(1-7), also known as A-779 (MAS receptor antagonist).<sup><xref ref-type="bibr" rid="bibr14-1470320311417273">14</xref></sup> Serum concentrations of Ang-(1-7) are similar to those observed for AngII.<sup><xref ref-type="bibr" rid="bibr15-1470320311417273">15</xref></sup> However, the effect of AngII and Ang-(1-7) are similar in some tissues (for example, brain),<sup><xref ref-type="bibr" rid="bibr16-1470320311417273">16</xref></sup> and different in others (for example, kidney and heart).<sup><xref ref-type="bibr" rid="bibr17-1470320311417273">17</xref></sup></p>
<p>In ovarian tissue, Ang-(1-7) was shown to induce an increase in estradiol and progesterone levels in perfused rat ovary, which was inhibited by A-779.<sup><xref ref-type="bibr" rid="bibr18-1470320311417273">18</xref></sup> It was also shown that the expression of mRNA for MAS and ACE<sub>2</sub> increased in rat ovaries treated with equine chorionic gonadotropin (eCG),<sup><xref ref-type="bibr" rid="bibr5-1470320311417273">5</xref></sup> suggesting a possible regulation mediated by gonadotropins. However, the function of Ang-(1-7) in the ovary is little understood, and far less is known in mono-ovulatory species. Cattle, a mono-ovulatory species, provide several advantages as a model for studying periovulatory events. The time between the gonadotropin surge and ovulation is long enough (24–30 h) to allow an analysis of events over time.<sup><xref ref-type="bibr" rid="bibr19-1470320311417273">19</xref></sup> The cow’s reproductive tract enables monitoring of follicular size, and the ovulatory follicle can be identified early in the follicular wave. Also, ovaries, follicles, follicular fluids and theca and granulosa cells can be easily obtained. Moreover, the follicular environment can be modified by intrafollicular injection for in vivo studies.</p>
<p>This work was based on the hypothesis that Ang-(1-7) is present and regulated during the ovulation process in cattle. Therefore, the aim of the present study was to determine the presence and the concentration of Ang-(1-7) in the follicular fluid and the mRNA expression of MAS receptor, ACE<sub>2</sub>, NEP and PEP in follicular cells of preovulatory follicles before and after the expected time of LH surge in the cow.</p>
</sec>
<sec id="section2-1470320311417273" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="section3-1470320311417273">
<title>Animals, ovariectomy and follicles</title>
<p>A total of 40 cyclic females (<italic>Bos taurus taurus</italic>), multiparous, with body condition scores of 3 and 4 (1 = thin, 5 = obese) were used in this study in accordance with procedures approved by the Ethics and Animal Welfare Committee of the Federal University of Santa Maria (n°: 23081.004717/2010-53 - CCR / UFSM). Cows received two doses of a PGF2α analogue (cloprostenol, 250 mg; Schering-Plough Animal Health, Brazil) i.m., 12 h apart, 2 mg of estradiol benzoate (EB) and an intravaginal progesterone device on day ‘0’ (progesterone, 1 g; DIB®, Intervet/Schering-Plough, Brazil).</p>
<p>After intravaginal device removal (day 9), ovaries were examined by transrectal ultrasonography, using a 8 MHz linear-array transducer (AquilaVet scanner, Pie Medical, Netherlands) and cows that had gonadotropin-releasing hormone (GnRH)-responsive preovulatory follicles (≥12 mm) were challenged with 100 µg of gonadorelin acetate (Profertil®, Tortuga, Brazil) i.m. 12 h after removal of the intravaginal progesterone device. GnRH-treated cows were then ovariectomized at different time-points (0, 3, 6, 12 and 24 h) post-GnRH, as previously described by Komar et al.,19 via colpotomy in the standing position, as described by Drost et al.<sup><xref ref-type="bibr" rid="bibr20-1470320311417273">20</xref></sup> Immediately after ovariectomy, follicular fluid was recovered and each cell type (granulosa and theca) was isolated according to Buratini et al.<sup><xref ref-type="bibr" rid="bibr21-1470320311417273">21</xref></sup> Granulosa cells were stored in 600 µl RLT buffer (Qiagen, Mississauga, ON, Canada) and theca cells in 600 µl Trizol (Invitrogen, Brazil), both in cryogenic tubes. Samples were immediately frozen in liquid nitrogen where they remained until the samples were processed for analysis (hormonal dosage in follicular fluid or mRNA extraction from cells).</p>
<p>Cross-contamination between theca and granulosa cells was tested by real-time polymerase chain reaction (qRT-PCR) to detect cytochrome P450 aromatase (CYP19A1) and 17α-hydroxylase (CYP17A1) mRNA. Granulosa cells that expressed CYP17A1 and theca cells that expressed CYP19A1 were discarded.<sup><xref ref-type="bibr" rid="bibr22-1470320311417273">22</xref></sup> Follicular fluid destined for Ang-(1-7) measurement was stored in the presence of the following protease inhibitors: 10-5 M phenylmethylsulfonylfluoride, 10-5 M pepstatin A, 10-5 M EDTA, 10-5 M p-hydroxymercuribenzoate, and 9 × 10-4 M orthophenanthroline, all purchased from Sigma-Aldrich Corp.</p>
</sec>
<sec id="section4-1470320311417273">
<title>Angiotensin-(1-7) measurement</title>
<p>Ang-(1-7) was measured as described by Simões et al.<sup><xref ref-type="bibr" rid="bibr23-1470320311417273">23</xref></sup> Briefly, the follicular fluid samples were thawed and processed for peptide extraction through Bond-Elut C-18 cartridges (Analytichem International, Harbor City, CA, USA), then lyophilized on a speed vacuum concentrator, and reconstituted to 65% of the original volume with dilution buffer (NaCl 0.9%, BSA 0.12%, acetic acid 0.03%). Ang-(1-7) was quantified in the reconstituted samples by radioimmunoassay (RIA). The polyclonal Ang-(1-7) antibody used for the RIA presented a cross-reactivity of less than 0.01% with other angiotensin peptides. Volumes of reconstituted follicular fluid (50 µL) were incubated for 18–22 h with Ang-(1-7)-specific antibody and with [125I]Ang-(1-7) (6000–8000 cpm/tube) in a final volume of 0.7 ml of 100 mM Tris-acetate buffer, pH 7.4, containing 5% BSA. The minimal detection limit of the Ang-(1-7) RIA was 2.5 pg. The inter- and intra-assay variability was 7.8% and 3.5%, respectively.</p>
</sec>
<sec id="section5-1470320311417273">
<title>Nucleic acid extraction and qRT-PCR</title>
<p>Total RNA was extracted using Trizol (theca cells) or a silica-based protocol (granulosa cells; Qiagen, Mississauga, ON, Canada) according to the manufacturer’s instructions and was quantified by absorbance at 260 nm. Total RNA (1 µg) was first treated with 0.2 U DNase (Invitrogen) at 37°C for 5 min to digest any contaminating DNA, followed by heating to 65°C for 3 min. The RNA was reverse transcribed (RT) in the presence of 1 µM oligo (dT), primer, 4 U Omniscript RTase (Omniscript RT Kit; Qiagen, Mississauga, ON, Canada), 0.5 µM dideoxynucleotide triphosphate (dNTP) mix, and 10 U RNase Inhibitor (Invitrogen) in a volume of 20 µl at 37°C for 1 h. The reaction was terminated by incubation at 93°C for 5 min.</p>
<p>The qRT-PCR was conducted in a Step One Plus instrument (Applied Biosystems, Foster City, CA, USA) with Platinum SYBR Green qRT-PCR SuperMix (Invitrogen) and bovine-specific primers (<xref ref-type="table" rid="table1-1470320311417273">Table 1</xref>). Common thermal cycling parameters (3 min at 95°C, 40 cycles of 15 s at 95°C, 30 s at 60°C, and 30 s at 72°C) were used to amplify each transcript. Melting-curve analyses were performed to verify product identity. Samples were run in duplicate and were expressed relative to cyclophilin (used as housekeeping gene). The relative quantification of gene expression across treatments was evaluated using the ddCT method.<sup><xref ref-type="bibr" rid="bibr24-1470320311417273">24</xref></sup> Briefly, the dCT was calculated as the difference between the CT of the investigated gene and the CT of cyclophilin in each sample. The ddCT of each investigated gene was calculated as the difference between the dCT in each treated sample and the dCT of the sample with lower gene expression (higher dCT). The fold change in relative mRNA concentrations was calculated using the formula 2–ddCT. Bovine-specific primers (<xref ref-type="table" rid="table1-1470320311417273">Table 1</xref>) were taken from literature or designed using Primer Express Software v3.0 (Applied Biosystems) and synthesized by Invitrogen. In all experiments, gene expression consisted of no less than 4–6/time point.</p>
<table-wrap id="table1-1470320311417273" position="float">
<label>Table 1.</label>
<caption><p>Primers used in the expression analysis of candidate genes. Primer sequences and concentrations used to amplify each product are described</p></caption>
<graphic alternate-form-of="table1-1470320311417273" xlink:href="10.1177_1470320311417273-table1.tif"/>
<table>
<colgroup>
<col align="left"/>
<col align="left"/>
<col align="left"/>
<col align="char" char="."/>
<col align="left"/>
</colgroup>
<thead>
<tr>
<th align="left">Gene</th>
<th/>
<th align="left">Sequence</th>
<th align="left">Conc. (µM)</th>
<th align="left">Reference or accession nº</th>
</tr>
</thead>
<tbody>
<tr>
<td>ACE<sub>2</sub>
</td>
<td>F</td>
<td>TGACTACAGCCGTGACCAGTTG</td>
<td>200</td>
<td>ENSBTAT00000044222</td>
</tr>
<tr>
<td/>
<td>R</td>
<td>CAACTTTGCCCTCACATAAGCA</td>
<td>200</td>
<td/>
</tr>
<tr>
<td>CYCLOPHILIN</td>
<td>F</td>
<td>GGTCATCGGTCTCTTTGGAA</td>
<td>200</td>
<td>36</td>
</tr>
<tr>
<td/>
<td>R</td>
<td>TCCTTGATCACACGATGGAA</td>
<td>200</td>
<td/>
</tr>
<tr>
<td>MAS</td>
<td>F</td>
<td>CGTGATCATCTTCATAGCCATTCT</td>
<td>200</td>
<td>ENSBTAT00000003723</td>
</tr>
<tr>
<td/>
<td>R</td>
<td>CCACGAGTTCTTCCGGATCTT</td>
<td>200</td>
<td/>
</tr>
<tr>
<td>PEP</td>
<td>F</td>
<td>GTTCCTCGACCCCAACACACT</td>
<td>200</td>
<td>ENSBTAT00000021658</td>
</tr>
<tr>
<td/>
<td>R</td>
<td>GGCACTCAGACCATAGGCAAA</td>
<td>200</td>
<td/>
</tr>
<tr>
<td>NEP</td>
<td>F</td>
<td>CCTGCTGCTCACCATCATTG</td>
<td>200</td>
<td>ENSBTAT00000002681</td>
</tr>
<tr>
<td/>
<td>R</td>
<td>TCGAGCGGCTGATTTTATGC</td>
<td>200</td>
<td/>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1470320311417273">
<p>F: Forward primer, R: Reverse primer, Conc.: primer concentration used for gene amplification.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section6-1470320311417273">
<title>Enzyme-linked immunosorbent assay (ELISA)</title>
<p>Follicular fluid was assayed using ELISA to determine estradiol concentration following the manufacturer’s instructions (Cayman Biochemical).</p>
</sec>
<sec id="section7-1470320311417273">
<title>Statistical analysis</title>
<p>The results were analyzed by analysis of variance (ANOVA) and multi-comparison between hours was performed by least square means. Data were tested for normal distribution using the Shapiro–Wilk test and normalized when necessary. All analyses were performed using JMP software (SAS Institute Inc., Cary, NC, USA) and a p &lt; 0.05 was considered statistically significant. Data are presented as mean ± SEM.</p>
</sec>
</sec>
<sec id="section8-1470320311417273" sec-type="results">
<title>Results</title>
<sec id="section9-1470320311417273">
<title>Validation of experimental model</title>
<p>The follicular diameter did not change at different time-points after GnRH challenge (prior to ovariectomy, evaluated by ultrasound; <xref ref-type="fig" rid="fig1-1470320311417273">Figure 1A</xref>). To determine the follicular status (healthy or atretic), follicular fluid was obtained from all dissected follicles. The follicular fluid estradiol concentration increased (p &lt; 0.05) 3 h after treatment with GnRH (expected time of endogenous LH surge), and gradually decreased thereafter, until 24 h (p &lt; 0.05; <xref ref-type="fig" rid="fig1-1470320311417273">Figure 1B</xref>).</p>
<fig id="fig1-1470320311417273" position="float">
<label>Figure 1.</label>
<caption><p>Follicular diameter (mm) at the time of ovariectomy (<italic>n</italic> = at least 5–6/time point - A) and estradiol concentration (B) in follicular fluid obtained from preovulatory follicles at 0, 3, 6, 12, or 24 h after GnRH analogue challenge to induce an LH surge (pg/ml mean ± standard error of mean; <italic>n</italic> = at least 5/time point). Different letters represent statistical difference (<italic>p</italic> &lt; 0.05).</p></caption>
<graphic xlink:href="10.1177_1470320311417273-fig1.tif"/>
</fig>
</sec>
<sec id="section10-1470320311417273">
<title>Follicular fluid Ang-(1-7) concentrations</title>
<p>The concentrations of Ang-(1-7) were measured in follicular fluid to test the hypothesis that follicular Ang-(1-7) secretion is regulated by the LH surge. Ang-(1-7) levels were constant until 12 h after GnRH, and then increased at 24 h after treatment (p &lt; 0.05; <xref ref-type="fig" rid="fig2-1470320311417273">Figure 2</xref>).</p>
<fig id="fig2-1470320311417273" position="float">
<label>Figure 2.</label>
<caption><p>Concentration of Ang-(1-7) (pg/ml mean ± standard error of mean; <italic>n</italic> = at least 6/time point) in follicular fluid obtained from preovulatory follicles at 0, 3, 6, 12, or 24 h after GnRH analogue challenge. Different letters represent statistical difference (<italic>p</italic> &lt; 0.05).</p></caption>
<graphic xlink:href="10.1177_1470320311417273-fig2.tif"/>
</fig>
</sec>
<sec id="section11-1470320311417273">
<title>Gene expression of MAS receptor, ACE<sub>2</sub>, NEP and PEP in theca and granulosa cells</title>
<p>The mRNA for MAS and enzymes was detected throughout the period after GnRH treatment in theca and granulosa cells. MAS receptor mRNA expression levels did not change after GnRH treatment in any cell type (<xref ref-type="fig" rid="fig3-1470320311417273">Figure 3A</xref> and <xref ref-type="fig" rid="fig3-1470320311417273">3B</xref>). ACE2 mRNA expression was only regulated in granulosa cells and revealed a transient downregulation until 12 h after GnRH injection, increasing again near ovulation (24 h after GnRH challenge) (<xref ref-type="fig" rid="fig4-1470320311417273">Figure 4</xref>). The mRNA expression of NEP increased after 12 h of GnRH challenge (p &lt; 0.05; <xref ref-type="fig" rid="fig5-1470320311417273">Figure 5A</xref>) while PEP decreased after GnRH and increased significantly at 24 h (p &lt; 0.05; <xref ref-type="fig" rid="fig6-1470320311417273">Figure 6A</xref>) in granulosa cells. However, the expression of both NEP and PEP did not change after GnRH in theca cells (<xref ref-type="fig" rid="fig5-1470320311417273">Figure 5B</xref> and <xref ref-type="fig" rid="fig6-1470320311417273">6B</xref>).</p>
<fig id="fig3-1470320311417273" position="float">
<label>Figure 3</label>
<caption><p>Relative mRNA expression (mean ± standard error of mean) of MAS receptor in granulosa (A) and theca (B) cells at different times after application of GnRH</p></caption>
<graphic xlink:href="10.1177_1470320311417273-fig3.tif"/>
</fig>
<fig id="fig4-1470320311417273" position="float">
<label>Figure 4</label>
<caption><p>Relative mRNA expression (mean ± standard error of mean) of angiotensin converting enzyme 2 (ACE<sub>2</sub>) in granulosa (A) and theca (B) cells at different times after application of GnRH. Different letters represent statistical difference (<italic>p</italic> &lt; 0.05).</p></caption>
<graphic xlink:href="10.1177_1470320311417273-fig4.tif"/>
</fig>
<fig id="fig5-1470320311417273" position="float">
<label>Figure 5</label>
<caption><p>Relative mRNA expression (mean ± standard error of mean) of neutral endopeptidase (NEP) in granulosa (A) and theca (B) cells at different times after application of GnRH. Different letters represent statistical difference (<italic>p</italic> &lt; 0.05).</p></caption>
<graphic xlink:href="10.1177_1470320311417273-fig5.tif"/>
</fig>
<fig id="fig6-1470320311417273" position="float">
<label>Figure 6.</label>
<caption><p>Relative mRNA expression (mean ± standard error of mean) of prolyl endopeptidase 2 (PEP) in granulosa (A) and theca (B) cells at different times after application of GnRH. Different letters represent statistical difference (<italic>p</italic> &lt; 0.05).</p></caption>
<graphic xlink:href="10.1177_1470320311417273-fig6.tif"/>
</fig>
</sec>
</sec>
<sec id="section12-1470320311417273" sec-type="discussion">
<title>Discussion</title>
<p>Our significant findings are: 1) the presence of the ACE<sub>2</sub>/Ang-(1-7)/MAS axis was demonstrated in periovulatory follicles in the cow using an in vivo model; 2) Ang-(1-7) increased in follicular fluid 24 h after GnRH; 3) differential mRNA expression of ACE<sub>2</sub>, NEP and PEP enzymes was observed in granulosa cells but not in theca cells during the periovulatory period; and 4) differential mRNA expression of MAS receptor was not detected in follicular cells from the periovulatory follicle.</p>
<p>The preovulatory gonadotropin surge induces a shift in follicular steroidogenesis from estradiol to progesterone,<sup><xref ref-type="bibr" rid="bibr25-1470320311417273">25</xref></sup> indicating a luteinization process of the follicular cells. In our in vivo experimental model, it appears that estradiol gradually decreased in the follicular fluid after a peak at 3 h post-GnRH injection, near the expected moment of LH surge, mimicking changes observed in another similar experimental model in vivo.<sup><xref ref-type="bibr" rid="bibr26-1470320311417273">26</xref></sup></p>
<p>NEP and PEP, but not ACE<sub>2</sub>, are upregulated in granulosa cells after GnRH treatment, though ACE<sub>2</sub> levels recover to the basal levels. Thus it appears that the increase in Ang-(1-7) 24 h after GnRH is mainly a result of cleavage of AngII and AngI (<xref ref-type="fig" rid="fig4-1470320311417273">Figure 4A</xref>, <xref ref-type="fig" rid="fig5-1470320311417273">5A</xref> and <xref ref-type="fig" rid="fig6-1470320311417273">6A</xref>). This effect may be due a higher conversion of other peptides of the RAS than AngI and AngII to Ang-(1-7). Acosta et al.<sup><xref ref-type="bibr" rid="bibr10-1470320311417273">10</xref></sup> observed a higher concentration of AngII only at 24 h after the LH surge. The fact that AngII levels increase after GnRH was further confirmed by our group (data not shown). Based on the facts that AngII levels increase near ovulation and mRNA expression for ACE<sub>2</sub>, NEP and PEP are upregulated in granulosa cells after GnRH treatment, we can postulate that the increase in Ang-(1-7) 24 h after GnRH was a result of AngII cleavage. It is well established that AngII is essential in the initial mechanism of ovulation in cattle.<sup><xref ref-type="bibr" rid="bibr4-1470320311417273">4</xref></sup> The effects attributed to AngII during ovulation<sup><xref ref-type="bibr" rid="bibr3-1470320311417273">3</xref>,<xref ref-type="bibr" rid="bibr4-1470320311417273">4</xref>,<xref ref-type="bibr" rid="bibr8-1470320311417273">8</xref>,<xref ref-type="bibr" rid="bibr27-1470320311417273">27</xref></sup> and oocyte maturation<sup><xref ref-type="bibr" rid="bibr3-1470320311417273">3</xref>,<xref ref-type="bibr" rid="bibr6-1470320311417273">6</xref>,<xref ref-type="bibr" rid="bibr8-1470320311417273">8</xref></sup> may be mediated at least in part by Ang-(1-7).</p>
<p>Our results revealed that preovulatory follicles expressed mRNA for enzymes that cleave AngI and II to give rise to Ang-(1-7). In a previous study, we found that AngII is present in follicular fluid and that ovulation in cattle is inhibited by an intrafollicular injection of saralasin (a competitive inhibitor of AngII) in the first 6 h after GnRH challenge. Furthermore, Ang-(1–7) stimulated arachidonic acid, prostaglandins and nitric oxide in tissue other than ovarian cells,<sup><xref ref-type="bibr" rid="bibr28-1470320311417273">28</xref>,<xref ref-type="bibr" rid="bibr29-1470320311417273">29</xref></sup> and prostaglandins are essential for ovulation.<sup><xref ref-type="bibr" rid="bibr30-1470320311417273">30</xref>-<xref ref-type="bibr" rid="bibr32-1470320311417273">32</xref></sup> Together, these results suggest that AngII is required at the beginning of ovulation and is then converted to Ang-(1-7) at the end of the ovulation period.</p>
<p>The mRNA expression of NEP and PEP enzymes in the ovary of a mono-ovulatory species had not been previously described. In rats, NEP enzymatic activity decreased and PEP increased after eCG treatment.<sup><xref ref-type="bibr" rid="bibr5-1470320311417273">5</xref></sup> In our experimental model, the mRNA expression pattern of NEP and PEP enzymes in preovulatory follicular cells followed similar patterns after GnRH treatment. Regarding Ang(1-7) receptor, in rats the mRNA expression for MAS in ovary homogenates was upregulated after eCG treatment.<sup><xref ref-type="bibr" rid="bibr5-1470320311417273">5</xref></sup> The hypothesis that the MAS receptor expression pattern changes during ovulation in cattle was not confirmed. These results provide an evidence of species-specific regulation of the ACE<sub>2</sub>/Ang-(1-7)/MAS axis during the ovulatory process.</p>
<p>The concentration of Ang-(1-7) and AngII (data not shown) increased after GnRH treatment in vivo. Inhibitors of ACE and PEP inhibited the LH-stimulated progesterone in rat luteal cells, suggesting that the conversion of AngII to Ang-(1-7) mediates steroidogenesis in the corpus luteum.<sup><xref ref-type="bibr" rid="bibr33-1470320311417273">33</xref></sup> The depletion of MAS negatively affected the expression of steroidogenic enzymes in the testis, such as StAR and 3β-HSDs.<sup><xref ref-type="bibr" rid="bibr34-1470320311417273">34</xref></sup> These results help to understand the increase in concentration of Ang-(1-7) at the end of ovulation process.</p>
<p>It is known that ACE<sub>2</sub> is expressed in granulosa cells and that Ang-(1-7) is present in the follicular fluid of women.<sup><xref ref-type="bibr" rid="bibr35-1470320311417273">35</xref></sup> Ang-(1-7) levels are higher in proestrus and estrus compared with metestrus and diestrus in rat ovaries.<sup><xref ref-type="bibr" rid="bibr18-1470320311417273">18</xref></sup> Ang-(1-7) also induced an increase in concentrations of estradiol and progesterone, which was inhibited by A-779.<sup><xref ref-type="bibr" rid="bibr18-1470320311417273">18</xref></sup> Here we report for the first time that Ang-(1-7) and ACE<sub>2</sub>, NEP and PEP mRNA expression are regulated after GnRH treatment. Taken together, these results indicate a role of Ang-(1-7) in ovulation/luteinization in cattle.</p>
<p>In conclusion, mRNA for MAS receptor, ACE<sub>2</sub>, NEP and PEP is expressed in theca and granulosa cells during the periovulatory period. The differential expression of the mRNA of these enzymes in response to the LH surge associated with an increase of Ang-(1-7) concentrations in follicular fluid suggests the involvement of Ang-(1-7) in the regulatory process of ovulation in cattle.</p>
</sec>
</body>
<back>
<ack>
<p>The authors would like to thank the Leão and Guassupi ranches for providing the animals used in this work. We are very grateful to Dr Vinicius de Oliveira for the animals’ facilities.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p>This study was supported by Brazilian Council of Scientific and Technological Development (CNPq # 474238/2009/1).</p>
</fn>
<fn fn-type="conflict">
<p>The authors declare that they have no conflicts of interest.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1470320311417273">
<label>1.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sartori</surname><given-names>R</given-names></name>
<name><surname>Fricke</surname><given-names>PM</given-names></name>
<name><surname>Ferreira</surname><given-names>JC</given-names></name>
<name><surname>Ginther</surname><given-names>OJ</given-names></name>
<name><surname>Wiltbank</surname><given-names>MC</given-names></name>
</person-group>. <article-title>Follicular deviation and acquisition of ovulatory capacity in bovine follicles</article-title>. <source>Biol Reprod</source> <year>2001</year>; <volume>65</volume>: <fpage>1403</fpage>–<lpage>1409</lpage>.</citation>
</ref>
<ref id="bibr2-1470320311417273">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reel</surname><given-names>JR</given-names></name>
<name><surname>Gorski</surname><given-names>J</given-names></name>
</person-group>. <article-title>Gonadotrophic regulation of precursor incorporation into ovarian RNA, protein, and acid-soluble fractions. I. Effects of pregnant mare serum gonadotrophin (PMSG), follicle-stimulating hormone (FSH), and luteinizing hormone (LH)</article-title>. <source>Endocrinology</source> <year>1968</year>; <volume>83</volume>: <fpage>1083</fpage>–<lpage>1091</lpage>.</citation>
</ref>
<ref id="bibr3-1470320311417273">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshimura</surname><given-names>Y</given-names></name>
<name><surname>Karube</surname><given-names>M</given-names></name>
<name><surname>Aoki</surname><given-names>H</given-names></name>
<etal/>
</person-group>. <article-title>Angiotensin II induces ovulation and oocyte maturation in rabbit ovaries via the AT2 receptor subtype</article-title>. <source>Endocrinology</source> <year>1996</year>; <volume>137</volume>: <fpage>1204</fpage>–<lpage>1211</lpage>.</citation>
</ref>
<ref id="bibr4-1470320311417273">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ferreira</surname><given-names>R</given-names></name>
<name><surname>Oliveira</surname><given-names>JF</given-names></name>
<name><surname>Fernandes</surname><given-names>R</given-names></name>
<name><surname>Moraes</surname><given-names>JF</given-names></name>
<name><surname>Goncalves</surname><given-names>PB</given-names></name>
</person-group>. <article-title>The role of angiotensin II in the early stages of bovine ovulation</article-title>. <source>Reproduction</source> <year>2007</year>; <volume>134</volume>: <fpage>713</fpage>–<lpage>719</lpage>.</citation>
</ref>
<ref id="bibr5-1470320311417273">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pereira</surname><given-names>VM</given-names></name>
<name><surname>Reis</surname><given-names>FM</given-names></name>
<name><surname>Santos</surname><given-names>RA</given-names></name>
<etal/>
</person-group>. <article-title>Gonadotropin stimulation increases the expression of angiotensin-(1–7) and MAS receptor in the rat ovary</article-title>. <source>Reprod Sci</source> <year>2009</year>; <volume>16</volume>: <fpage>1165</fpage>–<lpage>1174</lpage>.</citation>
</ref>
<ref id="bibr6-1470320311417273">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Barreta</surname><given-names>MH</given-names></name>
<name><surname>Oliveira</surname><given-names>JF</given-names></name>
<name><surname>Ferreira</surname><given-names>R</given-names></name>
<etal/>
</person-group>. <article-title>Evidence that the effect of angiotensin II on bovine oocyte nuclear maturation is mediated by prostaglandins E2 and F2alpha</article-title>. <source>Reproduction</source> <year>2008</year>; <volume>136</volume>: <fpage>733</fpage>–<lpage>740</lpage>.</citation>
</ref>
<ref id="bibr7-1470320311417273">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Giometti</surname><given-names>IC</given-names></name>
<name><surname>Bertagnolli</surname><given-names>AC</given-names></name>
<name><surname>Ornes</surname><given-names>RC</given-names></name>
<etal/>
</person-group>. <article-title>Angiotensin II reverses the inhibitory action produced by theca cells on bovine oocyte nuclear maturation</article-title>. <source>Theriogenology</source> <year>2005</year>; <volume>63</volume>: <fpage>1014</fpage>–<lpage>1025</lpage>.</citation>
</ref>
<ref id="bibr8-1470320311417273">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshimura</surname><given-names>Y</given-names></name>
<name><surname>Karube</surname><given-names>M</given-names></name>
<name><surname>Koyama</surname><given-names>N</given-names></name>
<name><surname>Shiokawa</surname><given-names>S</given-names></name>
<name><surname>Nanno</surname><given-names>T</given-names></name>
<name><surname>Nakamura</surname><given-names>Y</given-names></name>
</person-group>. <article-title>Angiotensin II directly induces follicle rupture and oocyte maturation in the rabbit</article-title>. <source>FEBS Lett</source> <year>1992</year>; <volume>307</volume>: <fpage>305</fpage>–<lpage>308</lpage>.</citation>
</ref>
<ref id="bibr9-1470320311417273">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Portela</surname><given-names>VM</given-names></name>
<name><surname>Goncalves</surname><given-names>PB</given-names></name>
<name><surname>Veiga</surname><given-names>AM</given-names></name>
<name><surname>Nicola</surname><given-names>E</given-names></name>
<name><surname>Buratini</surname><given-names>J</given-names><suffix>Jr.</suffix></name>
<name><surname>Price</surname><given-names>CA</given-names></name>
</person-group>. <article-title>Regulation of angiotensin type 2 receptor in bovine granulosa cells</article-title>. <source>Endocrinology</source> <year>2008</year>; <volume>149</volume>: <fpage>5004</fpage>–<lpage>5011</lpage>.</citation>
</ref>
<ref id="bibr10-1470320311417273">
<label>10.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Acosta</surname><given-names>TJ</given-names></name>
<name><surname>Ozawa</surname><given-names>T</given-names></name>
<name><surname>Kobayashi</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Periovulatory changes in the local release of vasoactive peptides, prostaglandin f(2alpha), and steroid hormones from bovine mature follicles in vivo</article-title>. <source>Biol Reprod</source> <year>2000</year>; <volume>63</volume>: <fpage>1253</fpage>–<lpage>1261</lpage>.</citation>
</ref>
<ref id="bibr11-1470320311417273">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Donoghue</surname><given-names>M</given-names></name>
<name><surname>Hsieh</surname><given-names>F</given-names></name>
<name><surname>Baronas</surname><given-names>E</given-names></name>
<etal/>
</person-group>. <article-title>A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9</article-title>. <source>Circ Res</source> <year>2000</year>; <volume>87</volume>: <fpage>E1</fpage>–<lpage>E9</lpage>.</citation>
</ref>
<ref id="bibr12-1470320311417273">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Santos</surname><given-names>RA</given-names></name>
<name><surname>Brosnihan</surname><given-names>KB</given-names></name>
<name><surname>Jacobsen</surname><given-names>DW</given-names></name>
<name><surname>DiCorleto</surname><given-names>PE</given-names></name>
<name><surname>Ferrario</surname><given-names>CM</given-names></name>
</person-group>. <article-title>Production of angiotensin-(1-7) by human vascular endothelium</article-title>. <source>Hypertension</source> <year>1992</year>; <volume>19</volume>: <fpage>I156</fpage>–<lpage>I161</lpage>.</citation>
</ref>
<ref id="bibr13-1470320311417273">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Santos</surname><given-names>RA</given-names></name>
<name><surname>Simoes</surname><given-names>e</given-names></name>
<name><surname>Silva</surname><given-names>AC</given-names></name>
<name><surname>Maric</surname><given-names>C</given-names></name>
<etal/>
</person-group>. <article-title>Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor MAS</article-title>. <source>Proc Natl Acad Sci U S A</source> <year>2003</year>; <volume>100</volume>: <fpage>8258</fpage>–<lpage>8263</lpage>.</citation>
</ref>
<ref id="bibr14-1470320311417273">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Dilauro</surname><given-names>M</given-names></name>
<name><surname>Burns</surname><given-names>KD</given-names></name>
</person-group>. <article-title>Angiotensin-(1-7) and its effects in the kidney</article-title>. <source>Sci World J</source> <year>2009</year>; <volume>9</volume>: <fpage>522</fpage>–<lpage>535</lpage>.</citation>
</ref>
<ref id="bibr15-1470320311417273">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Campbell</surname><given-names>DJ</given-names></name>
<name><surname>Lawrence</surname><given-names>AC</given-names></name>
<name><surname>Towrie</surname><given-names>A</given-names></name>
<name><surname>Kladis</surname><given-names>A</given-names></name>
<name><surname>Valentijn</surname><given-names>AJ</given-names></name>
</person-group>. <article-title>Differential regulation of angiotensin peptide levels in plasma and kidney of the rat</article-title>. <source>Hypertension</source> <year>1991</year>; <volume>18</volume>: <fpage>763</fpage>–<lpage>773</lpage>.</citation>
</ref>
<ref id="bibr16-1470320311417273">
<label>16.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Santos</surname><given-names>RA</given-names></name>
<name><surname>Campagnole-Santos</surname><given-names>MJ</given-names></name>
<name><surname>Andrade</surname><given-names>SP</given-names></name>
</person-group>. <article-title>Angiotensin-(1-7): an update</article-title>. <source>Regul Pept</source> <year>2000</year>; <volume>91</volume>: <fpage>45</fpage>–<lpage>62</lpage>.</citation>
</ref>
<ref id="bibr17-1470320311417273">
<label>17.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Santos</surname><given-names>RA</given-names></name>
<name><surname>Ferreira</surname><given-names>AJ</given-names></name>
<name><surname>Simoes</surname><given-names>ESAC</given-names></name>
</person-group>. <article-title>Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-MAS axis</article-title>. <source>Exp Physiol</source> <year>2008</year>; <volume>93</volume>: <fpage>519</fpage>–<lpage>527</lpage>.</citation>
</ref>
<ref id="bibr18-1470320311417273">
<label>18.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Costa</surname><given-names>AP</given-names></name>
<name><surname>Fagundes-Moura</surname><given-names>CR</given-names></name>
<name><surname>Pereira</surname><given-names>VM</given-names></name>
<etal/>
</person-group>. <article-title>Angiotensin-(1-7): a novel peptide in the ovary</article-title>. <source>Endocrinology</source> <year>2003</year>; <volume>144</volume>: <fpage>1942</fpage>–<lpage>1948</lpage>.</citation>
</ref>
<ref id="bibr19-1470320311417273">
<label>19.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Komar</surname><given-names>CM</given-names></name>
<name><surname>Berndtson</surname><given-names>AK</given-names></name>
<name><surname>Evans</surname><given-names>AC</given-names></name>
<name><surname>Fortune</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Decline in circulating estradiol during the periovulatory period is correlated with decreases in estradiol and androgen, and in messenger RNA for p450 aromatase and p450 17alpha-hydroxylase, in bovine preovulatory follicles</article-title>. <source>Biol Reprod</source> <year>2001</year>; <volume>64</volume>: <fpage>1797</fpage>–<lpage>1805</lpage>.</citation>
</ref>
<ref id="bibr20-1470320311417273">
<label>20.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Drost</surname><given-names>M</given-names></name>
<name><surname>Savio</surname><given-names>JD</given-names></name>
<name><surname>Barros</surname><given-names>CM</given-names></name>
<name><surname>Badinga</surname><given-names>L</given-names></name>
<name><surname>Thatcher</surname><given-names>WW</given-names></name>
</person-group>. <article-title>Ovariectomy by colpotomy in cows</article-title>. <source>J Am Vet Med Assoc</source> <year>1992</year>; <volume>200</volume>: <fpage>337</fpage>–<lpage>339</lpage>.</citation>
</ref>
<ref id="bibr21-1470320311417273">
<label>21.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Buratini</surname><given-names>J</given-names><suffix>Jr.</suffix></name>
<name><surname>Pinto</surname><given-names>MG</given-names></name>
<name><surname>Castilho</surname><given-names>AC</given-names></name>
<etal/>
</person-group>. <article-title>Expression and function of fibroblast growth factor 10 and its receptor, fibroblast growth factor receptor 2B, in bovine follicles</article-title>. <source>Biol Reprod</source> <year>2007</year>; <volume>77</volume>: <fpage>743</fpage>–<lpage>750</lpage>.</citation>
</ref>
<ref id="bibr22-1470320311417273">
<label>22.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Buratini</surname><given-names>J</given-names><suffix>Jr.</suffix></name>
<name><surname>Teixeira</surname><given-names>AB</given-names></name>
<name><surname>Costa</surname><given-names>IB</given-names></name>
<etal/>
</person-group>. <article-title>Expression of fibroblast growth factor-8 and regulation of cognate receptors, fibroblast growth factor receptor-3c and -4, in bovine antral follicles</article-title>. <source>Reproduction</source> <year>2005</year>; <volume>130</volume>: <fpage>343</fpage>–<lpage>350</lpage>.</citation>
</ref>
<ref id="bibr23-1470320311417273">
<label>23.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Simoes</surname><given-names>ESAC</given-names></name>
<name><surname>Diniz</surname><given-names>JS</given-names></name>
<name><surname>Regueira Filho</surname><given-names>A</given-names></name>
<name><surname>Santos</surname><given-names>RA</given-names></name>
</person-group>. <article-title>The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1-7) in essential hypertension</article-title>. <source>J Pediatr</source> <year>2004</year>; <volume>145</volume>: <fpage>93</fpage>–<lpage>98</lpage>.</citation>
</ref>
<ref id="bibr24-1470320311417273">
<label>24.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Livak</surname><given-names>KJ</given-names></name>
<name><surname>Schmittgen</surname><given-names>TD</given-names></name>
</person-group>. <article-title>Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT method</article-title>. <source>Methods</source> <year>2001</year>; <volume>25</volume>: <fpage>402</fpage>–<lpage>408</lpage>.</citation>
</ref>
<ref id="bibr25-1470320311417273">
<label>25.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Tsafriri</surname><given-names>A</given-names></name>
<name><surname>Eckstein</surname><given-names>B</given-names></name>
</person-group>. <article-title>Changes in follicular steroidogenic enzymes following the preovulatory surge of gonadotropins and experimentally-induced atresia</article-title>. <source>Biol Reprod</source> <year>1986</year>; <volume>34</volume>: <fpage>783</fpage>–<lpage>787</lpage>.</citation>
</ref>
<ref id="bibr26-1470320311417273">
<label>26.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Bridges</surname><given-names>PJ</given-names></name>
<name><surname>Komar</surname><given-names>CM</given-names></name>
<name><surname>Fortune</surname><given-names>JE</given-names></name>
</person-group>. <article-title>Gonadotropin-induced expression of messenger ribonucleic acid for cyclooxygenase-2 and production of prostaglandins E and F2alpha in bovine preovulatory follicles are regulated by the progesterone receptor</article-title>. <source>Endocrinology</source> <year>2006</year>; <volume>147</volume>: <fpage>4713</fpage>–<lpage>4722</lpage>.</citation>
</ref>
<ref id="bibr27-1470320311417273">
<label>27.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kuji</surname><given-names>N</given-names></name>
<name><surname>Sueoka</surname><given-names>K</given-names></name>
<name><surname>Miyazaki</surname><given-names>T</given-names></name>
<etal/>
</person-group>. <article-title>Involvement of angiotensin II in the process of gonadotropin-induced ovulation in rabbits</article-title>. <source>Biol Reprod</source> <year>1996</year>; <volume>55</volume>: <fpage>984</fpage>–<lpage>991</lpage>.</citation>
</ref>
<ref id="bibr28-1470320311417273">
<label>28.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Muthalif</surname><given-names>MM</given-names></name>
<name><surname>Benter</surname><given-names>IF</given-names></name>
<name><surname>Uddin</surname><given-names>MR</given-names></name>
<name><surname>Harper</surname><given-names>JL</given-names></name>
<name><surname>Malik</surname><given-names>KU</given-names></name>
</person-group>. <article-title>Signal transduction mechanisms involved in angiotensin-(1-7)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells</article-title>. <source>J Pharmacol Exp Ther</source> <year>1998</year>; <volume>284</volume>: <fpage>388</fpage>–<lpage>398</lpage>.</citation>
</ref>
<ref id="bibr29-1470320311417273">
<label>29.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Zimpelmann</surname><given-names>J</given-names></name>
<name><surname>Burns</surname><given-names>KD</given-names></name>
</person-group>. <article-title>Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells</article-title>. <source>Am J Physiol Renal Physiol</source> <year>2009</year>; <volume>296</volume>: <fpage>F337</fpage>–<lpage>346</lpage>.</citation>
</ref>
<ref id="bibr30-1470320311417273">
<label>30.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Yoshimura</surname><given-names>Y</given-names></name>
<name><surname>Dharmarajan</surname><given-names>AM</given-names></name>
<name><surname>Gips</surname><given-names>S</given-names></name>
<etal/>
</person-group>. <article-title>Effects of prostacyclin on ovulation and microvasculature of the in vitro perfused rabbit ovary</article-title>. <source>Am J Obstet Gynecol</source> <year>1988</year>; <volume>159</volume>: <fpage>977</fpage>–<lpage>982</lpage>.</citation>
</ref>
<ref id="bibr31-1470320311417273">
<label>31.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Sirois</surname><given-names>J</given-names></name>
<name><surname>Sayasith</surname><given-names>K</given-names></name>
<name><surname>Brown</surname><given-names>KA</given-names></name>
<name><surname>Stock</surname><given-names>AE</given-names></name>
<name><surname>Bouchard</surname><given-names>N</given-names></name>
<name><surname>Dore</surname><given-names>M</given-names></name>
</person-group>. <article-title>Cyclooxygenase-2 and its role in ovulation: a 2004 account</article-title>. <source>Hum Reprod Update</source> <year>2004</year>; <volume>10</volume>: <fpage>373</fpage>–<lpage>385</lpage>.</citation>
</ref>
<ref id="bibr32-1470320311417273">
<label>32.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Fortune</surname><given-names>JE</given-names></name>
<name><surname>Willis</surname><given-names>EL</given-names></name>
<name><surname>Bridges</surname><given-names>PJ</given-names></name>
<name><surname>Yang</surname><given-names>CS</given-names></name>
</person-group>. <article-title>The periovulatory period in cattle: progesterone, prostaglandins, oxytocin and ADAMTS proteases</article-title>. <source>Anim Reprod</source> <year>2009</year>; <volume>6</volume>: <fpage>60</fpage>–<lpage>71</lpage>.</citation>
</ref>
<ref id="bibr33-1470320311417273">
<label>33.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Pepperell</surname><given-names>JR</given-names></name>
<name><surname>Nemeth</surname><given-names>G</given-names></name>
<name><surname>Yamada</surname><given-names>Y</given-names></name>
<name><surname>Naftolin</surname><given-names>F</given-names></name>
<name><surname>Merino</surname><given-names>M</given-names></name>
</person-group>. <article-title>Localized accumulation of angiotensin II and production of angiotensin-(1-7) in rat luteal cells and effects on steroidogenesis</article-title>. <source>Am J Physiol Endocrinol Metab</source> <year>2006</year>; <volume>291</volume>: <fpage>E221</fpage>–<lpage>E233</lpage>.</citation>
</ref>
<ref id="bibr34-1470320311417273">
<label>34.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Xu</surname><given-names>P</given-names></name>
<name><surname>Santos</surname><given-names>RA</given-names></name>
<name><surname>Bader</surname><given-names>M</given-names></name>
<name><surname>Alenina</surname><given-names>N</given-names></name>
</person-group>. <article-title>Alterations in gene expression in the testis of angiotensin-(1-7)-receptor Mas-deficient mice</article-title>. <source>Regul Pept</source> <year>2007</year>; <volume>138</volume>: <fpage>51</fpage>–<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr35-1470320311417273">
<label>35.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Reis</surname><given-names>FM</given-names></name>
<name><surname>Bouissou</surname><given-names>DR</given-names></name>
<name><surname>Pereira</surname><given-names>VM</given-names></name>
<name><surname>Camargos</surname><given-names>AF</given-names></name>
<name><surname>Dos Reis</surname><given-names>AM</given-names></name>
<name><surname>Santos</surname><given-names>RA</given-names></name>
</person-group>. <article-title>Angiotensin-(1-7), its receptor MAS, and the angiotensin-converting enzyme type 2 are expressed in the human ovary</article-title>. <source>Fertil Steril</source> <year>2011</year>; <volume>95</volume>: <fpage>176</fpage>–<lpage>181</lpage>.</citation>
</ref>
<ref id="bibr36-1470320311417273">
<label>36.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ledoux</surname><given-names>S</given-names></name>
<name><surname>Campos</surname><given-names>DB</given-names></name>
<name><surname>Lopes</surname><given-names>FL</given-names></name>
<name><surname>Dobias-Goff</surname><given-names>M</given-names></name>
<name><surname>Palin</surname><given-names>MF</given-names></name>
<name><surname>Murphy</surname><given-names>BD</given-names></name>
</person-group>. <article-title>Adiponectin induces periovulatory changes in ovarian follicular cells</article-title>. <source>Endocrinology</source> <year>2006</year>; <volume>147</volume>: <fpage>5178</fpage>–<lpage>5186</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>